UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Genome-wide association study identifies MAPT locus influencing human plasma tau levels

Chen, J; Yu, J-T; Wojta, K; Wang, H-F; Zetterberg, H; Blennow, K; Yokoyama, JS; ... Boxer, AL; + view all (2017) Genome-wide association study identifies MAPT locus influencing human plasma tau levels. Neurology , 88 (7) pp. 669-676. 10.1212/WNL.0000000000003615. Green open access

[thumbnail of Zetterberg_Neurology-2017-Chen-669-76.pdf]
Preview
Text
Zetterberg_Neurology-2017-Chen-669-76.pdf - Published Version

Download (653kB) | Preview

Abstract

OBJECTIVE: To identify genetic loci associated with plasma tau concentrations in healthy elders and individuals with Alzheimer disease. METHODS: Four hundred sixty-three non-Hispanic white individuals exceeding quality control criteria were included from the Alzheimer's Disease Neuroimaging Initiative (ADNI-1) cohort. Association of plasma tau with genetic polymorphisms was performed with a linear regression model. Significant associations were validated in an independent replication cohort consisting of 431 healthy elders or individuals with mild cognitive impairment recruited from the University of California, San Francisco Memory and Aging Center. RESULTS: The minor allele (A) of rs242557 in the microtubule-associated protein tau gene (MAPT) was associated with higher plasma tau levels at genome-wide significance (p = 4.85 × 10−9, empiric family-wise error corrected p = 0.0024) in a dose-dependent fashion. This association was also observed in the replication cohort (p = 1.0 × 10−5; joint analysis p = 1.2 × 10−12). Single nucleotide polymorphisms near PARK2 (rs2187213) (p = 6.15 × 10−6), IL2RA (rs7072793, rs7073236) (p = 7.89 × 10−6), and an intergenic locus on 9p21.3 (rs7047280) (p = 8.13 × 10−6) were identified as suggestive loci associated with plasma tau levels. CONCLUSIONS: MAPT H1c haplotype (rs242557) has previously been identified as a genetic risk factor for progressive supranuclear palsy and corticobasal degeneration. The current findings suggest that plasma tau concentration could be an endophenotype for identifying risk for 4-repeat tauopathies in older individuals.

Type: Article
Title: Genome-wide association study identifies MAPT locus influencing human plasma tau levels
Open access status: An open access version is available from UCL Discovery
DOI: 10.1212/WNL.0000000000003615
Publisher version: http://doi.org/10.1212/WNL.0000000000003615
Language: English
Additional information: © 2017 American Academy of Neurology. This version is the version of record. For information on re-use, please refer to the publisher’s terms and conditions.
Keywords: Science & Technology, Life Sciences & Biomedicine, Clinical Neurology, Neurosciences & Neurology, PROGRESSIVE SUPRANUCLEAR PALSY, CEREBROSPINAL-FLUID, ALZHEIMERS-DISEASE, CORTICOBASAL DEGENERATION, GENE-EXPRESSION, RISK VARIANTS, HAPLOTYPE, TAUOPATHIES, MUTATIONS, REGION
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Neurodegenerative Diseases
URI: https://discovery.ucl.ac.uk/id/eprint/1551087
Downloads since deposit
100Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item